From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective

被引:1
|
作者
Rester, Ulrich [1 ]
机构
[1] Bayer HealthCare, Global Drug Discovery, Lead Generat & Optimizat, Med Chem, D-42096 Elberfeld, Germany
关键词
drug design; ITC; NMR; virtual screening; x-ray crystallography;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug discovery and development is an interdisciplinary, expensive and time-consuming process. Scientific advancements during the past two decades have altered the way pharmaceutical research produces novel bio-active molecules. Advances in computational techniques and hardware solutions have enabled in silico methods, and in particular virtual screening, to speed up modern lead identification and lead optimization. Recent successes have proven the power of combining virtual screening with complementary and synergistic biophysical methods, such as X-ray crystallography, NMR spectroscopy and isothermal titration calorimetry (ITC). This review addresses key issues, challenges and recent improvements of virtual screening methods and strategies. Examples highlighting the impact of an ntegrated virtual screening and biophysical characterization platform in the lead identification and optimization process are presented and discussed.
引用
收藏
页码:559 / 568
页数:10
相关论文
共 50 条
  • [41] Fragment-to-Lead Medicinal Chemistry Publications in 2016
    Johnson, Christopher N.
    Erlanson, Daniel A.
    Jahnke, Wolfgang
    Mortenson, Paul N.
    Rees, David C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 1774 - 1784
  • [42] Fragment-to-Lead Medicinal Chemistry Publications in 2015
    Johnson, Christopher N.
    Erlanson, Daniel A.
    Murray, Christopher W.
    Rees, David C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (01) : 89 - 99
  • [43] Fragment-to-Lead Medicinal Chemistry Publications in 2022
    Woodhead, Andrew J.
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Holvey, Rhian S.
    Jahnke, Wolfgang
    Pathuri, Puja
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2287 - 2304
  • [44] FROM VIRTUAL REALITY TO TANGIBLE VIRTUALITY: AN INVENTORY OF THE TECHNOLOGICAL CHALLENGES
    Horvath, Imre
    Rusak, Zoltan
    de Smit, Bram
    Kooijman, Adrie
    Opiyo, Eliab Z.
    WINVR2009: PROCEEDINGS OF THE ASME/AFM WORLD CONFERENCE ON INNOVATIVE VIRTUAL REALITY - 2009, 2009, : 45 - 57
  • [45] Basics of Virtual Reality. From the Discovery of Perspective to VR Glasses
    Wade, Nicholas J.
    PERCEPTION, 2022, 51 (06) : 438 - 439
  • [46] Subtleties in GPCR drug discovery: a medicinal chemistry perspective
    Fujioka, Masahiko
    Omori, Naoki
    DRUG DISCOVERY TODAY, 2012, 17 (19-20) : 1133 - 1138
  • [47] Lead discovery - RAMPing up NMR screening
    Kirkpatrick, P
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) : 773 - 773
  • [48] "MedChemVR": A Virtual Reality Game to Enhance Medicinal Chemistry Education
    Abuhammad, Areej
    Falah, Jannat
    Alfalah, Salasabeel F. M.
    Abu-Tarboush, Muhannad
    Tarawneh, Ruba T.
    Drikakis, Dimitris
    Charissis, Vassilis
    MULTIMODAL TECHNOLOGIES AND INTERACTION, 2021, 5 (03)
  • [49] Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example
    Rollinger, JM
    Haupt, S
    Stuppner, H
    Langer, T
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (02): : 480 - 488
  • [50] High-throughput and virtual screening: core lead discovery technologies move towards integration
    Good, AC
    Krystek, SR
    Mason, JS
    DRUG DISCOVERY TODAY, 2000, 5 (12) : S61 - S69